Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Lindahl

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Trends in Cardiovascular Medicine|January 15, 2011
Tissue factor pathway inhibitor in health and diseaseA K Lindahl
Current Opinion in Lipidology|December 1, 1994
Tissue factor pathway inhibitor: a potent inhibitor of in-vitro coagulation and in-vivo thrombus formationA K Lindahl
Thrombosis Research|October 15, 1991
The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitorA K Lindahl, U Abildgaard, R Staalesen
British Journal of Haematology|September 12, 1998
Elevated TFPI in malignant disease: relation to cancer type and hypercoagulationN Iversen, A K Lindahl, U Abildgaard
Haemostasis|January 1, 1990
Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarctionA K Lindahl, P M Sandset, U Abildgaard
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1988
The surgical treatment of gastric cancer: a retrospective study with special reference to total gastrectomyA K Lindahl, T B Harbitz, I Liavåg
Haemostasis|January 1, 1991
Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human bloodU Abildgaard, A K Lindahl, P M Sandset
Thrombosis and Haemostasis|February 1, 1993
Increased plasma thrombomodulin in cancer patientsA K Lindahl, M C Boffa, U Abildgaard
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1992
The present status of tissue factor pathway inhibitorA K Lindahl, P M Sandset, U Abildgaard
Thrombosis Research. Supplement|January 1, 1991
Involvement of the extrinsic pathway in the activities of low molecular weight heparinsL Norrheim, U Abildgaard, M L Larsen, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Trends in Cardiovascular Medicine|January 15, 2011
Tissue factor pathway inhibitor in health and diseaseA K Lindahl
Current Opinion in Lipidology|December 1, 1994
Tissue factor pathway inhibitor: a potent inhibitor of in-vitro coagulation and in-vivo thrombus formationA K Lindahl
Thrombosis Research|October 15, 1991
The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitorA K Lindahl, U Abildgaard, R Staalesen
British Journal of Haematology|September 12, 1998
Elevated TFPI in malignant disease: relation to cancer type and hypercoagulationN Iversen, A K Lindahl, U Abildgaard
Haemostasis|January 1, 1990
Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarctionA K Lindahl, P M Sandset, U Abildgaard
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1988
The surgical treatment of gastric cancer: a retrospective study with special reference to total gastrectomyA K Lindahl, T B Harbitz, I Liavåg
Haemostasis|January 1, 1991
Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human bloodU Abildgaard, A K Lindahl, P M Sandset
Thrombosis and Haemostasis|February 1, 1993
Increased plasma thrombomodulin in cancer patientsA K Lindahl, M C Boffa, U Abildgaard
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1992
The present status of tissue factor pathway inhibitorA K Lindahl, P M Sandset, U Abildgaard
Thrombosis Research. Supplement|January 1, 1991
Involvement of the extrinsic pathway in the activities of low molecular weight heparinsL Norrheim, U Abildgaard, M L Larsen, et al.
Pageof 3